More on LXEO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-26.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lexeo Therapeutics (NQ:LXEO)
Delayed: 4.93 -0.05 (1%)
Prev. Close $4.98  
Open$4.99 
52 Wk High$ 
52 Wk Low$ 
Day High$5.34 
Day Low$4.92 
P/E N/A  
EPS$ 
Volume1,481,284 

Friends, Peers and Foes (?): DYN, QURE, BHVN, DSGN, PTCT (more...)

Jun 17, 2026 04:01 PM Lexeo phase I/II data for Friedreich ataxia gene therapy published
Jun 17, 2026 04:01 PM Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
Jun 15, 2026 07:06 AM Form 8-K Lexeo Therapeutics, Inc. For: Jun 15
Jun 15, 2026 07:01 AM Lexeo finalizes pivotal trial design for gene therapy in heart condition
Jun 15, 2026 07:00 AM Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
May 20, 2026 04:31 PM Form 4 Lexeo Therapeutics, Inc. For: May 18 Filed by: Otero Jose Manuel
May 20, 2026 04:30 PM Form 4 Lexeo Therapeutics, Inc. For: May 18 Filed by: Townsend Richard Nolan
May 19, 2026 07:00 AM Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 18, 2026 03:42 PM Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
May 18, 2026 03:29 PM Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
View All Articles

Entities mentioned with LXEO

View All Entities